Quick Takeaways
- Shawn Tomasello has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $480,847.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Shawn Tomasello
- Location
- Sunnyvale, CA
- Summary
- The estimated net worth of Shawn Tomasello is at least $480,847 dollars as of 21 Jan 2026. Shawn Tomasello is the Director of Gamida Cell Ltd. and owns shares of Gamida Cell Ltd. stock worth about $375.1K. Shawn Tomasello is the Director of Allovir, Inc. and owns shares of Kalaris Therapeutics, Inc. (KLRS) stock worth about $55.5K. Shawn Tomasello is the Director of Cabaletta Bio, Inc. and owns shares of Cabaletta Bio, Inc. (CABA) stock worth about $50.3K.
- Signature
- By: /s/ Michael Gerard, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Shawn Tomasello and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Gamida Cell Ltd. ($375,064).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Shawn Tomasello
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GMDA | Gamida Cell Ltd. | Director | $375,064 | 31 Jan 2024 | ||
| KLRS | Allovir, Inc. | Director | $55,461 | 06 Jun 2024 | ||
| CABA | Cabaletta Bio, Inc. | Director | $50,322 | +$50,322 | +100% | 21 Jan 2026 |
| FDMT | 4D Molecular Therapeutics, Inc. | Director | 17 Jun 2025 | |||
| TCRR | TCR2 THERAPEUTICS INC. | Director | 01 Jun 2023 | |||
| URGN | UroGen Pharma Ltd. | Director | 07 Jun 2021 |
Insider Transactions Reported by Shawn Tomasello:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.